A novel macrophage-biomimetic drug delivery system carrying Saikosaponin D was reported to inhibit cell migration of MCF-7 and 4T1 cells in vitro and significantly reduced tumor growth and lung and spleen metastasis by promoting dephosphorylation of AKT and Erk in tumor-bearing mice (89). Here, AKT1 is linked to neoplasm.